Follow this blog:
RSS

Genome sequencing turns to another target: patients with genetic diseases

By | March 12, 2010, 11:03 AM PST

Nearly a dozen genomes of people of all shapes and sizes have been decoded, but until now, they’ve all had one thing in common: they were healthy.

Now, two independent research teams have completely sequenced the genomes of people who suffer from genetic disease.

In the first, Baylor College of Medicine’s Richard Gibbs sequenced the entire genome of his colleague James Lupski, a medical geneticist who carries the genes for Charcot-Marie-Tooth disease, a nerve disorder.

In the second, Leroy Hood and David Galas of Seattle’s Institute for Systems Biology decoded the genomes of two children (and their parents) who carry two rare genetic diseases.

All three diseases are caused by single, rare mutations in a gene. More common diseases such as cancer are thought to be caused by mutations in several genes.

What the researchers discovered is that, in a surprising twist, the mutations that cause common diseases are not themselves common.

That goes entirely against the approach scientists have taken toward genetic diseases until now.

Instead, their findings suggest that fully sequencing genomes may instead help researchers explore the roots of common, multi-gene diseases — and in the case of the family genomes that were sequenced, improving the accuracy of the decoding process.

The teams’ work was published in the New England Journal of Medicine and the journal Science, respectively.

Related coverage on SmartPlanet:

[via New York Times]

Start your week smarter with our weekly e-mail newsletter. It's your cheat sheet for good ideas. Get it.

Andrew Nusca

About Andrew Nusca

Andrew Nusca is the editor of SmartPlanet.

Andrew Nusca

Andrew Nusca

Editor

Andrew Nusca is editor of SmartPlanet and an associate editor for ZDNet. Previously, he worked at Money, Men's Vogue and Popular Mechanics magazines. He holds degrees from the Columbia University Graduate School of Journalism and New York University. He based in New York but resides in Philadelphia.

Follow him on Twitter.

Andrew Nusca

Andrew Nusca
Andrew Nusca does not hold any investments in the companies he covers.
If you liked this, don't miss...
1
Comments

Join the conversation!

Follow via:
RSS
-1 Votes
+ -
RE: Genome sequencing turns to another target: patients with genetic diseases
Wake me up when there is a comprehensive test at a fair price (under
$300) that tells me everything I need to know to better forecast and
anticipate my health needs... and can put it all into an on-line
database where I can match up with others around the world to build
my family tree. It's basicaly all the same info, yet individual
comoanies on the Internet are now charging as little as $500 a pop
TO EVALUATE EACH DISEASE.

I have seen articles where certain celebrities and were charged in
excess of $160,000 for a battery of tests - luidicrous,. But I
suppose those celebrities neither care how much they spend of their
mega-millions nor have the intelligence to say "That's a stupid
idea!" or "WHAAAAAT?!? ARE YOU CRAZY??".

The two sides of the coin in stupidity and greed in this world never
ceases to amaze me... or maybe it already has.
Posted by bimjimmy
23rd Mar 2010
Join the conversation
Formatting +
BB Codes - Note: HTML is not supported in forums
  • [b] Bold [/b]
  • [i] Italic [/i]
  • [u] Underline [/u]
  • [s] Strikethrough [/s]
  • [q] "Quote" [/q]
  • [ol][*] 1. Ordered List [/ol]
  • [ul][*] · Unordered List [/ul]
  • [pre] Preformat [/pre]
  • [quote] "Blockquote" [/quote]

Join the SmartPlanet community and join the conversation! Signing up is fast and free. Don't wait -- we want to hear your opinion!